市場調查報告書
商品編碼
1426126
全球低溫保存設備市場:按設備、冷凍劑、應用、最終用戶、地區、機會、預測,2017-2031 年Cryopreservation Equipment Market Assessment, By Equipment, By Cryogen, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
2024-2031年預測期內,全球低溫保存設備市場規模將以12.48%的複合年增長率擴大,從2023年的76.4億美元增長到2031年的195.7億美元。 全球冷凍保存設備市場的成長是由多種因素推動的,例如不孕症的增加、體外受精需求的增加、技術進步、對幹細胞治療等再生醫學的認識不斷增強、醫療保健支出的增加以及政府舉措。因素。 製藥和生物技術公司的成長、公共和私營部門對低溫保存投資的增加以及幾家大公司和合併、收購、合作夥伴關係以及不斷推出新產品等發展策略正在推動全球低溫保存市場的發展。設備市場。
由於全球人口不孕症盛行率不斷上升,全球冷凍保存設備市場正在強勁成長。 荷爾蒙失衡、吸菸、飲酒、肥胖和接觸環境污染物是可能導致男性和女性不孕的一些危險因子。 隨著不孕症的增加,對體外受精的需求也增加。 體外受精過程需要冷凍保存設備來保存卵子和精子,因此對冷凍保存設備的需求不斷增加。 人們對再生療法的認識不斷提高,例如幹細胞療法在治療複雜疾病和損傷方面的成功,也在該市場的發展中發揮關鍵作用。 其他因素,例如醫療保健設施的改善、製藥和生物技術行業的成長以及公共和私營公司投資的增加,也進一步加速了低溫保存設備世界的成長。
領先公司在低溫保存設備方面的技術進步,例如創新的低溫保存技術以及開發高效冷凍機以維持低溫保存所需的適當溫度,已成為推動這一市場成長的主要因素。 各國政府也進行了低溫保存益處的宣傳活動,並提供資金支持低溫保存技術的研發,進一步擴大了全球低溫保存設備市場。 此外,公共和私營公司之間持續的合作夥伴關係和投資、新產品的推出、更高效和更有效的冷凍保存設備的研發增加以及市場新進入者的出現正在推動冷凍保存行業的發展,預計將為冷凍保存產業帶來光明的前景。
本報告調查了全球低溫保存設備市場,並提供了市場概述,以及按設備、冷凍劑、應用、最終用戶、地區和進入市場的公司概況劃分的趨勢。
Global cryopreservation equipment market is projected to witness a CAGR of 12.48% during the forecast period 2024-2031, growing from USD 7.64 billion in 2023 to USD 19.57 billion in 2031. Growth in the global cryopreservation equipment market is driven by various factors, such as the rising prevalence of infertility and increased demand for IVF, technological advancements, rising awareness regarding regenerative therapy like stem cell therapy, increased healthcare expenditure, and government initiatives. Growing pharmaceutical and biotechnological companies, increase in public and private sector investments in cryopreservation, and several leading players and developmental strategies like mergers, acquisitions, collaborations, and consistent new product launches accelerates the global cryopreservation equipment market growth.
The global cryopreservation equipment market is undergoing robust growth due to increasing prevalence of infertility among the population worldwide. Hormonal imbalance, smoking, alcohol consumption, obesity, and exposure to environmental pollutants are some of the risk factors leading to infertility among men and women. With increasing prevalence of infertility, demand for IVF also increases. IVF process requires cryopreservation equipment to preserve eggs and sperm, thereby creating the need for cryopreservation equipment. Increased awareness regarding regenerative therapy, such as the success of stem cell therapy in treating diseases and injuries that are complex to treat, also plays a crucial role in the development of this market. Other factors, such as improvement in healthcare facilities, growing pharmaceutical and biotechnological industries, and increased investments by public and private firms, further accelerate the growth of global cryopreservation equipment.
Technological advancements in cryopreservation equipment by leading players, such as the development of innovative cryopreservation techniques and highly efficient freezers to maintain the adequate temperature required for cryopreservation, are major factors responsible for the growth of this market. Governments are also initiating awareness campaigns regarding the benefits of cryopreservation and providing funds to support research and development in cryopreservation technologies, further expanding the global cryopreservation equipment market. Moreover, ongoing collaborations and investments among public and private companies, new product launches, increasing research and development of more efficient and effective cryopreservation equipment, and emerging new entrants in the market are expected to create a positive outlook for the cryopreservation equipment market.
For instance, in January 2024, Prince Edward Island Ignition Fund helped five island start-up companies launch their innovative products in the market. One of the 5 companies was NanoFreeze Solutions Inc., which received $25,000, for developing an innovative cryopreservation technology in the form of a non-toxic and inert Vitamin B5 Gel, which is highly efficient at freezing biological samples without compromising cell viability during the cryopreservation process.
Rising Prevalence of Infertility
There has been a surge in demand for cryopreservation equipment due to the rising prevalence of infertility worldwide. With modern lifestyle and environmental changes, more and more people are facing fertility issues. In-vitro fertilization (IVF) is the most common treatment option, adopted by couples to achieve pregnancy. Cryopreservation plays a vital role in IVF by preserving eggs, sperm, or embryos at extremely low temperatures. As the number of people affected by infertility is increasing, the application and demand for cryopreservation equipment are also growing. According to WHO, around 17.5% of the world's adult population is affected by infertility. This means that roughly 1 in 6 adults globally is facing infertility issues. In the year 2023, prevalence of infertility in high-income countries was 17.8% and it stood at 16.5% in low- and middle-income countries. Apart from biological factors, lifestyle factors, such as smoking, alcohol consumption and obesity, can lead to infertility in men and women. Due to this, the number of IVF procedures is increasing, which is further responsible for increased demand of cryopreservation equipment, thereby accelerating the growth of the global cryopreservation equipment market.
Technological Advancement in Cryopreservation Techniques
Technological advancements in cryopreservation techniques play a crucial role in the development and growth of the global market. Also, the role of healthcare providers and researchers in gaining in-depth insights into regenerative medicines, personalized medicines, fertility preservation options, and cryoprotectant solutions plays a very important role in the market's growth. Innovative advancements in this market contribute to improving the success rates, efficiency, and safety of cryopreservation techniques in several medical and scientific applications. Due to this, many key market players are investing in developing innovative techniques in cryopreservation to enhance their product portfolio and expand their business, resulting in the development of this market at a global level.
For instance, in July 2023, CryoStasis, which is a global leader in bringing a combination of chemistry, biochemistry, and cooling processes to provide cell preservation, announced that it has received $8 million fund from Genesys to develop next generation sub-zero unfrozen cryopreservation solutions for organ transplantation and cell/gene therapy products. This latest advancement would enable the healthcare providers, researchers, and healthcare industries to enhance current practices and develop new medical treatments, which can significantly improve patients' clinical outcomes. These technological advancements can bring revolutionary approach in cryopreservation techniques and escalate growth of the global cryopreservation equipment market.
Increased Demand for Freezers
Among the equipment segment, freezers hold the highest market share in the global cryopreservation equipment market. Freezers play a major role in cryopreservation by maintaining extremely low temperatures, which is crucial to preserve biological samples such as cells, tissues, or whole organisms. Extensive research and development activities and increased investments by key market players in this segment are providing a great boost to the cryopreservation equipment market. As several key market players are launching highly efficient freezers with the latest technology in their product portfolio, the cryopreservation equipment market is expected to grow tremendously in the future. For instance, in June 2023, BioLife Solutions, Inc., which is a leading developer of efficient bioproduction products for the cell and gene therapy, announced that it has launched a new, large-capacity controlled-rate freezer named as "IntelliRate i67C", to expand its product portfolio in the cryopreservation segment. IntelliRate i67C is a tabletop freezer that has the potential to fulfill crucial needs of its customer for higher volume production of cell therapies. Due to these consistent innovative launches by key market players, the global cryopreservation equipment market is witnessing rapid growth, which is expected to maintain in the future.
Increased Demand for Liquid Nitrogen
Among the cryogen segment, liquid nitrogen holds a significant market share in the overall global cryopreservation equipment market. In cryopreservation, biological samples, such as cells and tissues, are kept at extremely low temperature and among other cryogens, liquid nitrogen provides a much more stable ultra-low temperature environment. Due to this, liquid nitrogen is preferred for long-term storage. Moreover, as the demand for liquid nitrogen is increasing, key market players are expanding their business by establishing new liquid nitrogen plants in emerging regions, which is further accelerating growth of this segment. For instance, in May 2023, a new liquid nitrogen facility was established in the National Dairy Development Centre, Yusipang, Thimphu. The new facility was constructed to strengthen the Bhutan-India development partnership project under the 12th five-year plan of Bhutan. This new plant was developed under the livestock development project to increase production of milk, eggs, chicken, pork, fish, chevon, and honey in Bhutan. Moreover, it will help in meeting the increasing demand of liquid nitrogen for bovine semen cryopreservation and cold chain maintenance of valuable bovine semen. Key market players' frequent inauguration and establishment of liquid nitrogen facilities further propels the global cryopreservation equipment market.
North America Holds Major Share in the Market
North America holds the maximum share in the global cryopreservation equipment market due to its strong and robust healthcare infrastructure, increased healthcare spending, and growing investments by key market players in developing innovative cryopreservation techniques and equipment to improve cryopreservation facilities in the healthcare sector. Rise in prevalence of infertility in the United States has led to increased demand of IVF solutions that require cryopreservation equipment for preserving the eggs and sperms. Increased awareness regarding potential benefits of cryopreservation and regenerative therapies among the population is further escalating the market growth. Along with this, the frequent launch of innovative products by several key market players are also favoring the growth of the market in the region. For instance, in February 2022, OriGen Biomedical, Inc., which is a global medical device manufacturer of cryopreservation, cell culture, and respiratory products, announced the launch of its new CryoStore FLEX Freezing Bag in the USA and Europe. This product has also been granted CE mark approval for the CryoStore FLEX Freezing Bag product line. Moreover, the presence of leading market players within the region, such as Thermo Fisher Scientific, Inc. and BioLife Solutions Inc., further enhances the growth of the global cryopreservation equipment market in North America.
Future Market Scenario (2024 - 2031F)
The global cryopreservation equipment market is expected to rapidly grow in the future due to an increasing prevalence of infertility worldwide, which increases the demand for cryopreservation equipment in IVF processes. Increased healthcare expenditure and improvement in healthcare infrastructure, growing awareness regarding potential benefits of regenerative and stem cell therapies, government initiatives, increased research and development, new innovative launches by firms, and the emergence of new entrants are further escalating the growth of the global cryopreservation equipment market. Moreover, collaborative ventures involving manufacturers of analytical instruments from different industries have spurred innovation and growth in the global cryopreservation equipment market.
Key Players Landscape and Outlook
In the cryopreservation equipment market, public and private organizations and research institutes consistently establish initiatives, strategic partnerships, collaborations, and distribution agreements, which are crucial in propelling the global cryopreservation equipment market's expansion. These partnerships empower firms to gain from each other's strengths, benefit from access to new markets and technologies, and pool resources for research and development endeavors. Distribution agreements between the companies help them to broaden their market presence at an international level. These collaborative initiatives promote innovation and expedite product development and improved disease treatment, which, in turn, contribute to the enduring and robust growth of the overall healthcare industry.
For instance, in March 2023, Cryoport, Inc., a global leader in providing supply chain solutions for the reproductive medicine market and innovative temperature-controlled supply chain solutions for the life sciences industry, announced a 3-year partnership agreement with Inception Fertility, which is North America's largest comprehensive fertility services provider. This partnership aims to enhance and expand the company's existing cryopreservation product portfolio, grow its business in the fertility segment, expand the company's footprint in the North American region, and further elevate the global cryopreservation equipment market.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.